Evaluation of unfractionated heparin versus low‐molecular‐weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer

Autor: Van Matre, E.T., Reynolds, P.M., MacLaren, R., Mueller, S.W., Wright, G.C., Moss, M., Burnham, E.L., Ho, P.M., Vandivier, R.W., Kiser, T.H. *
Zdroj: In Journal of Thrombosis and Haemostasis December 2018 16(12):2492-2500
Databáze: ScienceDirect
Externí odkaz: